A researcher at the Sumatera Institute of Technology in Lampung has identified a compound in the mulberry plant with ...

Although deaths from cancer have gone down over the last couple decades, the disease remains one of the leading causes of death in the United States, just as it has for the last 75 years, according to ...

But manufacturing is still a difficult hurdle to overcome. Simone Steiner recently joined France’s Transgene as chief ...

It all started with frequent stomach aches about four years ago,” Mrs Agnes Acholi recalled. “From there, each episode of ...

The FDA has approved a groundbreaking new therapy for patients battling late-stage melanoma, offering hope when options run out.

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for ...

Antibody-Drug Conjugates (ADC) Market- Driven by Advanced Payload Technologies and Strategic Industry Partnerships Sai Kumar DataM Intelligence 4market Research LLP +1 877-441-4866 ... Visit us on ...

When Katie Doble was diagnosed with a rare cancer, she was given 16 months to live. Clinical trials gave her a second chance.

Human papillomaviruses, or HPVs, can cause dangerous infections in the skin and mucous membranes and may lead to cancer.

NSC51349 selectively inhibits cutaneous HPV replication by targeting viral E2 activity, potentially paving the way for first ...

Melanoma is a type of aggressive skin cancer that is the fifth most deadly cancer. Surgery, immunotherapy and chemo are the typical treatments. But now, the FDA has approved a groundbreaking new ...

Human papillomaviruses, or HPVs, can cause dangerous infections in the skin and mucous membranes and may lead to cancer.